Fewer than half of Americans recognize that drinking alcohol, diets high in red meat, diets low in vegetables, fruits and fiber and insufficient physical activity all have a clear link to cancer development, according to the American Institute for Cancer Research's ninth Cancer Risk Awareness Survey.
In the first comparative clinical trial of lung cancer screening decision aid versus standard educational information, researchers from MD Anderson Cancer Center demonstrated that a decision aid delivered through tobacco quitlines effectively reaches a screening-eligible population and results in informed decisions about lung cancer screening.
A study at MD Anderson Cancer Center showed that circulating tumor cells, a form of liquid biopsy, was independently associated with melanoma relapse, suggesting CTC assessment may be useful in identifying patients at risk for relapse who could benefit from more aggressive therapy following primary treatment.
A study analyzing new evolutionary complexity in uveal melanoma by J. William Harbour was published Jan. 24 in Nature Communications.
Satish Gopal was named director of the NCI Center for Global Health effective Feb. 3.
The Livestrong Foundation released an updated mission and a new logo.
Yilun LiuDavid AnnDavid Ann was named dean and Yilun Liu was named vice dean of the City of Hope graduate program.
Krystyna Kowalczyk was named CEO of Moffitt Cancer Center's new contract research organization with a focus on immunotherapy.
Brandi Felser was named executive director of The Sarcoma Foundation of America.
LUNGevity Foundation released its first Lung Cancer Scorecard that grades individual states on policies that support access to optimal care for lung cancer patients. These grades were assigned based upon five factors: coverage for lung cancer screening, coverage for comprehensive biomarker testing, Medicaid expansion, lung cancer incidence, and lung cancer survival.
